Skip to content
Screener

Astera Labs, Inc. ALAB Issuance of stock under employee stock plans

Issuance of stock under employee stock plans at other companies

Arteris, Inc. logo
Arteris, Inc.AIP
$447K-16.9%
Marvell Technology, Inc. logo
Marvell Technology, Inc.MRVL

Other financials

Income statement

See full
Revenue$392.4M+104%
Gross profit$287.6M+97.6%
Operating income$89.2M+124%
Net income$153.1M+199%
EPS (diluted)$0.83+186%

Balance sheet

See full
Cash & equivalents$111.5M-31.8%
Total debt$44.4M+37.5%
Total equity$1.7B+51.9%
Total assets$1.9B+51.9%

Cash flow

See full
Operating cash flow$87.7M-35.2%
CapEx$20.5M+912%
Free cash flow$67.2M-49.6%

Valuation

See full
Market cap$55.03B+84.7%
Enterprise value$54.97B+85.3%
P/E149×
P/S45.8×-3.4×

Profitability

See full
Gross margin75.1%-0.4pp
Operating margin22.8%+15.8pp
Net margin30.7%
FCF margin23%-11.7pp

Returns & leverage

See full
Return on equity25.8%
Debt / equity0.0×
Current ratio10.1×-1.0×

Where this comes from

Reported directly by Astera Labs, Inc. in its filing.

Tagged under the XBRL concept us-gaap:ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans.

The source filing: Astera Labs, Inc.’s 10-K, filed February 20, 2026.

Filed
Feb 20, 2026, 5:26 PM EST
Fiscal year
FY2025
Accession
0001736297-26-000010
Line itemYears Ended December 31, 2025Years Ended December 31, 2024Years Ended December 31, 2023
Proceeds from issuance of common stock in connection with initial public offering, net of underwriting discounts and commissions672,198
Payment of deferred offering costs(4,801)(1,407)
Proceeds from exercises of stock options1,8255,4581,115
Proceeds from employee stock purchase plan7,9784,160
Tax withholding related to net share settlements of restricted stock units(20,111)
Repurchase of common stock upon termination(1,066)(210)
Net cash provided by (used in) financing activities9,803655,838(502)
Net increase (decrease) in cash, cash equivalents, and restricted cash87,64034,946(30,990)

Item 8. Financial Statements and Supplementary Data

FAQ

What is Astera Labs, Inc.'s issuance of stock under employee stock plans?
Astera Labs, Inc. (ALAB) reported issuance of stock under employee stock plans of $3.63M in Q4 2025.
How has Astera Labs, Inc.'s issuance of stock under employee stock plans changed year-over-year?
Astera Labs, Inc.'s issuance of stock under employee stock plans decreased by 12.7% year-over-year, from $4.16M to $3.63M.
What does issuance of stock under employee stock plans mean?
Issuance of stock under employee stock plans

Ask your AI about Astera Labs, Inc.'s issuance of stock under employee stock plans.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude